Condition
Pneumocystis Pneumonia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Pneumocystis Pneumonia clinical trials that are recruiting, at sites in 5 countries (most in France (1), Canada (1), Italy (1)). By phase: Phase 1/2 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Pneumocystis Pneumonia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| FUNGAL-P: A score to spot fungal pneumonia early in adults with pneumonia | — | Florence | Recruiting | Jul 2, 2026 |
| Caspofungin Aerosols for Pneumocystis Pneumonia in Adults | Phase 1/2 | Orléans and 2 other locations | Recruiting | Mar 25, 2025 |
| Using caspofungin to treat Pneumocystis pneumonia in people with HIV. | — | Mexico City, Tlalpan | Recruiting | Nov 15, 2024 |
| Using rezafungin to treat Pneumocystis pneumonia in adults with HIV | Phase 2 | Cape Town and 5 other locations | Recruiting | Apr 28, 2023 |
| Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis (PCP) pneumonia | Phase 3 | Montreal, Quebec | Recruiting | Apr 20, 2021 |
All recruiting trials (5)
-
FUNGAL-P: A score to spot fungal pneumonia early in adults with pneumonia
Aimed at adults with pneumonia, this study tests a new score to help identify fungal pneumonia sooner so doctors can test appropriately and start antifungal treatment when needed.
-
Caspofungin Aerosols for Pneumocystis Pneumonia in Adults
This study tests daily caspofungin delivered as a nebulized spray added to standard treatment to see if it helps adults with Pneumocystis pneumonia.
-
Using caspofungin to treat Pneumocystis pneumonia in people with HIV.
This study is testing whether caspofungin can be a safer treatment for Pneumocystis pneumonia in people with HIV/AIDS compared to the usual medication.
-
Using rezafungin to treat Pneumocystis pneumonia in adults with HIV
This study is testing if adding a new drug called rezafungin to the standard treatment can help adults with HIV who have Pneumocystis pneumonia feel better.
-
Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis (PCP) pneumonia
This trial will test whether a lower daily dose of TMP‑SMX works as well but causes fewer side effects than the standard dose in adults with Pneumocystis (PCP) pneumonia who are immunocompromised.
Related topics
Quick answers
How many Pneumocystis Pneumonia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (1 trial), Canada (1 trial), Italy (1 trial), South Africa (1 trial), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.